Pliant Therapeutics, Inc.
US ˙ NasdaqGS ˙ US7291391057

Pengenalan

Halaman ini menyediakan analisis menyeluruh tentang sejarah dagangan orang dalam yang diketahui David E I Pyott. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Adalah haram bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat khusus bukan awam. Ini tidak bermakna haram bagi mereka untuk membuat sebarang perdagangan dalam syarikat mereka sendiri. Tetapi mereka mesti melaporkan semua perdagangan kepada SEC melalui Borang 4. Walaupun terdapat sekatan ini, penyelidikan akademik menunjukkan bahawa orang dalam - secara amnya - cenderung untuk mengatasi prestasi pasaran dalam syarikat mereka sendiri.

Purata Keuntungan Perdagangan

Purata keuntungan perdagangan ialah purata pulangan semua pembelian pasaran terbuka yang dibuat oleh orang dalam dalam tempoh tiga tahun terakhir. Untuk mengira ini, kami memeriksa setiap pembelian pasaran terbuka yang tidak dirancang oleh orang dalam, tidak termasuk semua dagangan yang ditandakan sebagai sebahagian daripada pelan dagangan 10b5-1. Kami kemudian mengira prestasi purata dagangan tersebut sepanjang 3, 6 dan 12 bulan, dengan purata setiap tempoh tersebut untuk menjana metrik prestasi akhir bagi setiap dagangan. Akhir sekali, kami puratakan semua metrik prestasi untuk mengira metrik prestasi untuk orang dalam. Senarai ini hanya termasuk orang dalam yang telah membuat sekurang-kurangnya tiga dagangan dalam dua tahun lepas.

Jika keuntungan berdagang orang dalam ini ialah "N/A", maka orang dalam sama ada tidak membuat sebarang pembelian pasaran terbuka dalam tempoh tiga tahun terakhir, atau dagangan yang mereka buat adalah terlalu baru untuk mengira metrik prestasi yang boleh dipercayai.

Kekerapan Kemas Kini: Harian

Lihat senarai pedagang dalaman yang paling menguntungkan.

Syarikat dengan Kedudukan Orang Dalam yang Dilaporkan

Pemfailan SEC menunjukkan David E I Pyott telah melaporkan pegangan atau perdagangan dalam syarikat berikut:

Sekuriti Tajuk Pegangan Terkini Dilaporkan
US:ALNY / Alnylam Pharmaceuticals, Inc. Director 911
US:BMRN / BioMarin Pharmaceutical Inc. Director 49,750
US:PLRX / Pliant Therapeutics, Inc. Director 13,286
US:AVY / Avery Dennison Corporation Director 0
Chairman of the Board and CEO, Director 0
US:EW / Edwards Lifesciences Corporation Director 1,874
Bagaimana Mentafsir Carta

Carta berikut menunjukkan prestasi saham sekuriti selepas setiap dagangan pasaran terbuka dan tidak dirancang yang dibuat oleh David E I Pyott. Perdagangan tidak dirancang ialah dagangan yang tidak dibuat sebagai sebahagian daripada pelan dagangan 10b5-1. Prestasi saham dicatatkan sebagai perubahan peratus kumulatif dalam harga saham. Sebagai contoh, jika perdagangan orang dalam dibuat pada 1 Januari 2019, carta akan menunjukkan perubahan peratusan harian sekuriti kepada hari ini. Jika harga saham naik dari $10 kepada $15 pada masa ini, perubahan peratus terkumpul dalam harga saham ialah 50%. Perubahan dalam harga daripada $10 kepada $20 ialah 100% dan perubahan dalam harga $10 hingga $5 ialah -50%.

Secara dasarnya, kami cuba untuk menentukan sejauh mana dagangan orang dalam berkait rapat dengan pulangan berlebihan (positif atau negatif) dalam harga saham untuk melihat sama ada orang dalam menetapkan masa dagangan mereka untuk mendapat keuntungan daripada maklumat orang dalam. Pertimbangkan situasi di mana orang dalam melakukan perkara ini. Dalam keadaan ini, kami menjangkakan sama ada (a) pulangan positif selepas pembelian, atau (b) pulangan negatif selepas jualan. Dalam kes (a), carta PEMBELIAN akan menunjukkan satu siri keluk condong ke atas, menunjukkan pulangan positif selepas setiap transaksi pembelian. Dalam kes (b), carta JUALAN akan menunjukkan satu siri keluk condong ke bawah, menunjukkan pulangan negatif selepas setiap transaksi jualan.

Walau bagaimanapun, ini sahaja tidak cukup untuk membuat kesimpulan. Jika, sebagai contoh, harga saham syarikat berada dalam pendakian bukan disebabkan kitaran selama bertahun-tahun, maka kami menjangkakan semua plot selepas pembelian akan condong ke atas. Begitu juga, kemerosotan bukan disebabkan kitaran selama bertahun-tahun akan mengakibatkan plot pasca perdagangan condong ke bawah. Kedua-dua carta ini tidak akan mencadangkan aktiviti perdagangan orang dalam.

Penunjuk terkuat ialah keadaan di mana harga saham adalah sangat kitaran, dan terdapat kedua-dua isyarat positif dalam carta PEMBELIAN dan plot negatif pada carta JUALAN. Situasi ini akan sangat menunjukkan orang dalam yang menentukan masa perdagangan untuk kelebihan kewangan mereka.

Pembelian Orang Dalam PLRX / Pliant Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam PLRX / Pliant Therapeutics, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Maks
Harga pada
Maks
Maks
Keuntungan ($)
Pulangan Maks (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

PLRX / Pliant Therapeutics, Inc. Insider Trades
Jualan Orang Dalam PLRX / Pliant Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam PLRX / Pliant Therapeutics, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Min
Harga pada
Min
Kerugian Maks
Dielakkan ($)
Kerugian Maks
Dielakkan (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

PLRX / Pliant Therapeutics, Inc. Insider Trades
Sejarah Dagangan Orang Dalam

Jadual ini menunjukkan senarai lengkap dagangan orang dalam yang dibuat oleh David E I Pyott seperti yang didedahkan kepada Suruhanjaya Bursa Sekuriti (SEC).

Tarikh Fail Tarikh Tran Borang Simbol Saham Sekuriti Kod 10b5-1 Saham Baki Saham Peratus
Ubah
Saham
harga
Tran
Nilai
Baki
Nilai
2025-05-12 2025-05-08 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 775 911 569.85
2025-03-25 2025-03-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7,440 136 -98.20 299.00 -2,224,560 40,664
2025-03-25 2025-03-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7,440 7,576 5,470.59 88.95 661,788 673,885
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7,470 136 -98.21 222.00 -1,658,340 30,192
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7,420 7,606 -49.38 221.00 -1,639,820 1,680,926
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -17,560 15,026 -53.89 220.00 -3,863,200 3,305,720
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7,470 32,586 29.74 71.99 537,765 2,345,866
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7,420 25,116 41.93 70.20 520,884 1,763,143
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 17,560 17,696 12,911.76 88.95 1,561,962 1,574,059
2024-05-23 2024-05-21 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,720 49,750 10.48
2023-05-24 2023-05-23 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,190 45,030 10.26
2023-02-27 2023-02-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 136 136
2022-05-26 2022-05-24 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,980 40,840 13.89
2022-05-20 2022-05-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 5,153 5,153
2022-02-25 2022-02-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 136 136
2021-07-19 2021-07-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4,032 4,032
2021-07-01 2021-06-29 4/A PLRX PLIANT THERAPEUTICS, INC.
Stock Option (right to buy)
A - Award 13,286 13,286
2021-06-30 2021-06-29 4 PLRX PLIANT THERAPEUTICS, INC.
Stock Option (right to buy)
A - Award 13,286 13,286
2021-05-27 2021-05-25 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 5,120 35,860 16.66
2021-01-13 2021-01-12 4 PLRX PLIANT THERAPEUTICS, INC.
Stock Option (right to buy)
A - Award 26,573 26,573
2020-09-01 2020-08-31 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
P - Purchase 900 30,740 3.02 78.84 70,955 2,423,520
2020-09-01 2020-08-31 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
P - Purchase 11,900 29,840 66.33 78.22 930,760 2,333,939
2020-07-06 2020-07-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4,581 4,581
2020-05-29 2020-05-27 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,300 17,940 31.52
2020-04-24 2020-04-23 4 AVY Avery Dennison Corp
2019 Director RSU Award
M - Exercise -1,414 0 -100.00
2020-04-24 2020-04-23 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1,414 18,684 8.19 107.56 152,090 2,009,651
2020-02-05 2020-02-03 4 AVY Avery Dennison Corp
2010 Director Stock Option
M - Exercise -5,027 0 -100.00
2020-02-05 2020-02-03 4 AVY Avery Dennison Corp
Common Stock
S - Sale -5,027 17,270 -22.55 132.72 -667,183 2,292,074
2020-02-05 2020-02-03 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 5,027 22,297 29.11 38.18 191,931 851,299
2019-07-02 2019-07-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 9,000 9,000
2019-06-06 2019-06-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,430 13,640 48.10
2019-05-02 2019-05-01 4 AVY Avery Dennison Corp
2019 Director RSU Award
A - Award 1,414 1,414
2019-05-02 2019-05-01 4 AVY Avery Dennison Corp
2018 Director RSU Award
M - Exercise -1,336 0 -100.00
2019-05-02 2019-05-01 4 AVY Avery Dennison Corp
2016 Director RSU Award
M - Exercise -641 0 -100.00
2019-05-02 2019-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1,336 17,270 8.38 109.63 146,466 1,893,310
2019-05-02 2019-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 641 15,934 4.19 109.63 70,273 1,746,844
2018-11-28 2018-11-27 4 AVY Avery Dennison Corp
2009 Director Stock Option
M - Exercise -2,000 0 -100.00
2018-11-28 2018-11-27 4 AVY Avery Dennison Corp
Common Stock
S - Sale -2,000 15,293 -11.57 93.00 -186,000 1,422,249
2018-11-28 2018-11-27 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 2,000 17,293 13.08 20.64 41,280 356,928
2018-06-22 2018-06-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 9,000 9,000
2018-06-07 2018-06-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,300 9,210 87.58
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
2018 Director RSU Award
A - Award 1,336 1,336
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
2017 Director RSU Award
M - Exercise -1,678 0 -100.00
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
2016 Director RSU Award
M - Exercise -641 641 -50.00
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
2015 Director RSU Award
M - Exercise -747 0 -100.00
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1,678 15,293 12.32 104.80 175,854 1,602,706
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 641 13,615 4.94 104.80 67,177 1,426,852
2018-05-02 2018-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 747 12,974 6.11 104.80 78,286 1,359,675
2017-08-30 2017-08-30 4 AVY Avery Dennison Corp
2008 Director Stock Option
M - Exercise -1,702 0 -100.00
2017-08-30 2017-08-30 4 AVY Avery Dennison Corp
Common Stock
S - Sale -1,702 16,303 -9.45 94.00 -159,988 1,532,482
2017-08-30 2017-08-30 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1,702 18,005 10.44 52.12 88,700 938,331
2017-08-30 2017-08-28 4 AVY Avery Dennison Corp
2008 Director Stock Option
M - Exercise -298 1,702 -14.90
2017-08-30 2017-08-28 4 AVY Avery Dennison Corp
Common Stock
S - Sale -298 16,303 -1.80 94.00 -28,012 1,532,482
2017-08-30 2017-08-28 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 298 16,601 1.83 52.12 15,530 865,161
2017-06-08 2017-06-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
A - Award 4,910 4,910
2017-06-08 2017-06-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 2,050 4,910 71.68
2017-06-06 2017-06-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 11,250 11,250
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
2017 Director RSU Award
A - Award 1,678 1,678
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
2016 Director RSU Award
M - Exercise -640 1,282 -33.30
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
2015 Director RSU Award
M - Exercise -746 747 -49.97
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
2014 Director RSU Award
M - Exercise -859 0 -100.00
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 640 16,303 4.09 83.42 53,389 1,359,996
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 746 15,663 5.00 83.42 62,231 1,306,607
2017-05-03 2017-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 859 14,917 6.11 83.42 71,658 1,244,376
2016-10-14 2016-10-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
P - Purchase 27,900 27,900 37.00 1,032,328 1,032,328
2016-08-09 2016-08-08 4 AVY Avery Dennison Corp
2006 Director Stock Option
M - Exercise -2,000 0 -100.00
2016-08-09 2016-08-08 4 AVY Avery Dennison Corp
Common Stock
S - Sale -2,000 14,058 -12.45 78.61 -157,220 1,105,099
2016-08-09 2016-08-08 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 2,000 16,058 14.23 67.80 135,590 1,088,652
2016-06-08 2016-06-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
A - Award 2,220 2,220
2016-06-08 2016-06-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 760 2,860 36.19
2016-06-07 2016-06-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 11,250 11,250
2016-05-02 2016-05-01 4 AVY Avery Dennison Corp
2016 Director RSU Award
A - Award 1,922 1,922
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
2015 Director RSU Award
M - Exercise -746 1,493 -33.32
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
2014 Director RSU Award
M - Exercise -859 859 -50.00
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
2013 Director RSU Award
M - Exercise -1,015 0 -100.00
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 746 14,058 5.60 72.82 54,324 1,023,704
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 859 13,312 6.90 72.82 62,552 969,380
2016-05-02 2016-04-29 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1,015 12,453 8.87 72.82 73,912 906,827
2016-01-06 2016-01-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
A - Award 6,100 6,100
2016-01-06 2016-01-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 2,100 2,100
2015-12-22 2015-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 25,000 25,000
2015-11-03 2015-11-02 4 AVY Avery Dennison Corp
2005 Director Stock Option
M - Exercise -2,000 0 -100.00
2015-11-03 2015-11-02 4 AVY Avery Dennison Corp
Common Stock
S - Sale -2,000 11,438 -14.88 64.88 -129,760 742,097
2015-11-03 2015-11-02 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 2,000 13,438 17.49 59.46 118,930 799,091
2015-05-04 2015-05-01 4 AVY Avery Dennison Corp
2015 Director RSU Award
A - Award 2,239 2,239
2015-05-04 2015-05-01 4 AVY Avery Dennison Corp
2014 Director RSU Award
M - Exercise -859 1,718 -33.33
2015-05-04 2015-05-01 4 AVY Avery Dennison Corp
2013 Director RSU Award
M - Exercise -1,015 1,015 -50.00
2015-05-04 2015-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 859 11,438 8.12 55.84 47,967 638,698
2015-05-04 2015-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1,015 10,579 10.61 55.84 56,678 590,731
2015-04-28 2015-04-26 4 AVY Avery Dennison Corp
2012 Director Rsu Award
M - Exercise -524 0 -100.00
2015-04-28 2015-04-26 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 524 9,564 5.80 51.77 27,127 495,128
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -257,756 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -422,400 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -303,000 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -533,000 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -312,000 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -375,000 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -410,000 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -386,800 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Common Stock
D - Sale to Issuer -114,548 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Common Stock
D - Sale to Issuer -2,897 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Common Stock
D - Sale to Issuer -2,180 0 -100.00
2015-03-19 2015-03-17 4 AGN ALLERGAN INC
Common Stock
D - Sale to Issuer -165,658 0 -100.00
2015-03-19 2015-02-12 4 AGN ALLERGAN INC
Common Stock
G - Gift -114,548 114,548 -50.00
2015-02-24 2015-02-20 4 AGN ALLERGAN INC
Restricted Stock Units
M - Exercise -1,379 0 -100.00
2015-02-24 2015-02-20 4 AGN ALLERGAN INC
Restricted Stock Units
A - Award 1,379 1,379
2015-02-24 2015-02-20 4 AGN ALLERGAN INC
Common Stock
F - Taxes -720 165,659 -0.43 234.00 -168,480 38,764,206
2015-02-24 2015-02-20 4 AGN ALLERGAN INC
Common Stock
M - Exercise 1,379 166,379 0.84
2014-12-02 2014-12-01 4 AVY Avery Dennison Corp
Common Stock Units - DDECP
A - Award 1,119 39,412 2.92
2014-05-13 2014-05-09 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 1,874 1,874
2014-05-13 2014-05-09 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 2,342 53,582 4.57
2014-05-02 2014-05-01 4 AVY Avery Dennison Corp
2013 Director RSU Award
M - Exercise -1,015 2,030 -33.33
2014-05-02 2014-05-01 4 AVY Avery Dennison Corp
Common Stock Units - DDECP
A - Award 1,289 37,754 3.54
2014-05-02 2014-05-01 4 AVY Avery Dennison Corp
2014 Director RSU Award
A - Award 2,577 2,577
2014-05-02 2014-05-01 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 1,015 9,040 12.65 48.50 49,228 438,440
2014-04-29 2014-04-28 4 AVY Avery Dennison Corp
2011 Director RSU
M - Exercise -391 0 -100.00
2014-04-29 2014-04-28 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 391 8,025 5.12 48.82 19,089 391,780
2014-04-29 2014-04-26 4 AVY Avery Dennison Corp
2012 Director RSU Award
M - Exercise -523 524 -49.95
2014-04-29 2014-04-26 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 523 7,634 7.35 48.70 25,473 371,814
2014-02-25 2014-02-21 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
A - Award 257,756 257,756 125.07 32,237,543 32,237,543
2014-02-13 2014-02-12 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
M - Exercise -252,000 0 -100.00
2014-02-13 2014-02-12 4 AGN ALLERGAN INC
Common Stock
S - Sale -252,000 165,000 -60.43 123.12 -31,025,560 20,314,354
2014-02-13 2014-02-12 4 AGN ALLERGAN INC
Common Stock
M - Exercise 252,000 417,000 152.73 36.15 9,109,800 15,074,550
2013-12-03 2013-12-01 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 1,278 36,046 3.68
2013-05-17 2013-05-15 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 2,250 2,250
2013-05-17 2013-05-15 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 2,811 51,240 5.80
2013-05-02 2013-05-01 4 AVY Avery Dennison Corp
2013 Director RSU Award
A - Award 3,045 3,045
2013-05-02 2013-05-01 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 774 34,313 2.31
2013-05-01 2013-05-01 4 EW Edwards Lifesciences Corp
Common Stock
P - Purchase 3,000 48,429 6.60 62.95 188,850 3,048,606
2013-04-29 2013-04-26 4 AVY Avery Dennison Corp
2012 Director RSU
M - Exercise -522 1,047 -33.27
2013-04-29 2013-04-26 4 AVY Avery Dennison Corp
2011 Director RSU
M - Exercise -390 391 -49.94
2013-04-29 2013-04-26 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 522 7,111 7.92 41.52 21,671 295,213
2013-04-29 2013-04-26 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 390 6,589 6.29 41.52 16,191 273,542
2013-04-23 2013-04-22 4 AVY Avery Dennison Corp
2010 Director RSU
M - Exercise -436 0 -100.00
2013-04-23 2013-04-22 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 436 6,199 7.57 40.85 17,811 253,229
2013-04-02 2013-04-01 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 983 33,539 3.02
2013-02-22 2013-02-21 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
A - Award 303,000 303,000
2012-12-20 2012-12-19 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 1,233 32,556 3.94
2012-10-05 2012-10-05 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
M - Exercise -307,956 0 -100.00
2012-10-05 2012-10-05 4 AGN ALLERGAN INC
Common Stock
S - Sale X -307,956 229,096 -57.34 93.72 -28,862,868 21,471,794
2012-10-05 2012-10-05 4 AGN ALLERGAN INC
Common Stock
M - Exercise X 307,956 537,052 134.42 41.24 12,700,105 22,148,024
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
M - Exercise -101,421 307,956 -24.77
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
M - Exercise -90,623 409,377 -18.12
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
M - Exercise -119,000 0 -100.00
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Common Stock
S - Sale X -101,421 229,096 -30.69 93.71 -9,504,486 21,469,319
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Common Stock
M - Exercise X 101,421 330,517 44.27 41.24 4,182,602 13,630,521
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Common Stock
M - Exercise X 90,623 229,096 65.44 41.24 3,737,293 9,447,919
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Common Stock
M - Exercise X 119,000 138,473 611.10 30.12 3,584,875 4,171,499
2012-10-05 2012-10-04 4 AGN ALLERGAN INC
Common Stock
S - Sale X -206,923 19,473 -91.40 93.74 -19,396,714 1,825,376
2012-10-05 2012-09-21 4 AGN ALLERGAN INC
Common Stock
G - Gift 19,473 226,396 9.41
2012-10-05 2012-09-21 4 AGN ALLERGAN INC
Common Stock
G - Gift -19,473 165,000 -10.56
2012-10-02 2012-09-28 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 1,179 31,323 3.91
2012-08-08 2012-08-06 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
M - Exercise -3,520 0 -100.00
2012-08-08 2012-08-06 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
M - Exercise -3,278 0 -100.00
2012-08-08 2012-08-06 4 EW Edwards Lifesciences Corp
Common Stock
S - Sale -6,798 45,429 -13.02 100.65 -684,199 4,572,297
2012-08-08 2012-08-06 4 EW Edwards Lifesciences Corp
Common Stock
M - Exercise 3,278 52,227 6.70 24.42 80,049 1,275,383
2012-08-08 2012-08-06 4 EW Edwards Lifesciences Corp
Common Stock
M - Exercise 3,520 48,949 7.75 22.72 79,957 1,111,877
2012-07-02 2012-06-29 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 1,304 30,144 4.52
2012-05-18 2012-05-16 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
G - Gift 312,000 312,000
2012-05-18 2012-05-16 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
G - Gift -312,000 0 -100.00
2012-05-14 2012-05-11 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 1,890 1,890
2012-05-14 2012-05-11 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 2,361 45,429 5.48
2012-04-30 2012-04-27 4 AVY Avery Dennison Corp
2011 Director RSU
M - Exercise -389 781 -33.25
2012-04-30 2012-04-27 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 389 5,763 7.24 32.36 12,586 186,462
2012-04-30 2012-04-26 4 AVY Avery Dennison Corp
2012 Director Stock Option
A - Award 6,318 6,318
2012-04-30 2012-04-26 4 AVY Avery Dennison Corp
2012 Director RSU Award
A - Award 1,569 1,569
2012-04-23 2012-04-20 4 AVY Avery Dennison Corp
2010 Director RSU
M - Exercise -437 436 -50.06
2012-04-23 2012-04-20 4 AVY Avery Dennison Corp
Common Stock
M - Exercise 437 5,374 8.85 31.33 13,691 168,367
2012-04-02 2012-03-30 4 AVY Avery Dennison Corp
Common Stock Units
A - Award 1,338 28,840 4.86
2012-02-22 2012-02-17 4 AGN ALLERGAN INC
Employee Stock Option (Right to Buy)
A - Award 312,000 312,000
2012-02-22 2012-02-17 4 AGN ALLERGAN INC
Common Stock
A - Award 2,045 185,563 1.11
2012-02-22 2012-02-17 4 AGN ALLERGAN INC
Common Stock
F - Taxes -955 183,518 -0.52 87.91 -83,954 16,133,067
2012-02-22 2012-02-17 4 AGN ALLERGAN INC
Common Stock
A - Award 165,000 184,473 847.33
2012-02-16 2012-02-14 4 AGN ALLERGAN INC
Common Stock
F - Taxes -12,869 18,383 -41.18 88.10 -1,133,823 1,619,634
2012-01-18 2012-01-18 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
M - Exercise X -20,000 0 -100.00
2012-01-18 2012-01-18 4 EW Edwards Lifesciences Corp
Common Stock
S - Sale X -20,000 43,068 -31.71 76.95 -1,539,060 3,314,212
2012-01-18 2012-01-18 4 EW Edwards Lifesciences Corp
Common Stock
M - Exercise X 20,000 63,068 46.44 12.88 257,700 812,631
2010-05-18 2010-05-14 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 796 796
2010-05-18 2010-05-14 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 1,987 29,286 7.28
2004-05-17 2004-05-13 4 EW EDWARDS LIFESCIENCES CORP
Common Stock
A - Award 4,000 9,000 80.00
P
Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif
S
Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif
A
Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)
C
Penukaran derivatif
D
Penjualan atau pemindahan sekuriti kembali kepada syarikat
F
Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat
G
Hadiah sekuriti oleh atau kepada orang dalam
K
Swap ekuiti dan urus niaga lindung nilai yang serupa
M
Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)
V
Transaksi dilaporkan secara sukarela pada Borang 4
J
Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)